Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia

Hematology

Volumn 7, Issue 2, 2002, Pages 69-74

  Meletis, John ^a   Terpos, Evangelos ^a   Samarkos, Michalis ^a   Meletis, Christos ^b   Apostolidou, Effie ^a   Komninaka, Veroniki ^a   Anargyrou, Konstantinos ^a   Korovesis, Konstantinos ^a   Mavrogianni, Despina ^a   Variami, Eleni ^a   Viniou, Nora ^a   Konstantopoulos, Konstantinos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Acute lymphoblastic leukemia (ALL); Acute non lymphoblastic leukemia (ANLL); Decay accelerating factor (DAF; CD55); Membrane inhibitor of reactivelysis (MIRL; CD59); Paroxysmal nocturnal hemoglobinuria (PNH)

Indexed keywords

ANTINEOPLASTIC AGENT; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; REGULATOR PROTEIN; SUCROSE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CANCER CLASSIFICATION; CELL INFILTRATION; CELL MEMBRANE; CELL POPULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ERYTHROCYTE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDICAL RECORD; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATIENT INFORMATION; PHENOTYPE; PRIORITY JOURNAL; TREATMENT OUTCOME; ACUTE DISEASE; BLOOD; DIAGNOSTIC PROCEDURE; IMMUNOLOGY; INCIDENCE; LEUKEMIA; MIDDLE AGED; PATHOLOGY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD55; DISEASE PROGRESSION; ERYTHROCYTES; FEMALE; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; INCIDENCE; LEUKEMIA; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PHENOTYPE;

EID: 0036290541     PISSN: 10245340     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330290028560     Document Type: Article

References (29)

1. "Complement regulation"
2. "Complement in the pathophysiology of human disease"
3. "Decay accelerating factor: Biochemistry, molecular biology and function"
4. "Complement. First of two parts"
5. "The dual pathogenesis of PNH"
6. "The cellular pathogenesis of paroxysmal nocturnal haemoglobinuria"
7. "Paroxysmal nocturnal hemoglobinuria: Learning about PNH cells from patients and mice"
8. "Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria"
9. "New insights into paroxysmal nocturnal hemoglobinuria"
10. "Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes"
11. "Paroxysmal nocturnal haemoglobinuria: Clinical presentation and association with other haematological disorders"
12. "Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anemia, myelodysplastic syndromes and myeloproliferative disorders"
13. "Detection of CD55 and/or CD59 deficient red cell populations in patients with lymphoproliferative syndromes"
14. "Detection of CD55 and/or CD59 deficient red cell populations in patients with plasma cell dyscrasias"
15. "Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies"
16. "Acute promyelocytic leukaemia with CD59 deficiency"
17. "Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies"
18. "The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukaemia (AML): Analysis of 1065 patients entered into the UK Medical Research Council AML11 trial"
19. - Erythrocytes in microtyping cards"
20. "Detection of "PNH Red Cell" populations in hematological disorders using the sephacryl gel test micro typing system"
21. "Leukemia arising out of paroxysmal nocturnal hemoglobinuria"
22. "PIG-A, DAF and proto-oncogene expression in paroxysmal nocturnal haemoglobinuria-associated acute myelogenous leukaemic blasts"
23. "Flow cytometric measurement of glycosylphosphatidylinositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria"
24. "Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting"
25. "Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines"
26. "Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down regulated during cell differentiation"
27. "Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals"
28. "Detection of small population of CD59-deficient erythrocytes in patients with aplastic anemia or myelodysplastic syndromes and normal individuals"
29. "The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment"